These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 26488834)

  • 1. Secondary Exposure of Family Members to Cyclophosphamide After Chemotherapy of Outpatients With Cancer: A Pilot Study.
    Yuki M; Ishida T; Sekine S
    Oncol Nurs Forum; 2015 Nov; 42(6):665-71. PubMed ID: 26488834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposure of family members to antineoplastic drugs via excreta of treated cancer patients.
    Yuki M; Sekine S; Takase K; Ishida T; Sessink PJ
    J Oncol Pharm Pract; 2013 Sep; 19(3):208-17. PubMed ID: 23060485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Occupational exposures among nurses caring for chemotherapy patients -Quantitative analysis of cyclophosphamide and α-fluoro-β-alanine in urine].
    Sasaki M; Ishii N; Kikuchi Y; Kudoh Y; Sugiyama R; Hasebe M
    Sangyo Eiseigaku Zasshi; 2016 Oct; 58(5):164-172. PubMed ID: 27488511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of urinary excretion of cyclophosphamide as a biomarker of exposure by studying its renal clearance at high and low plasma concentrations in cancer patients.
    Hedmer M; Höglund P; Cavallin-Ståhl E; Albin M; Jönsson BA
    Int Arch Occup Environ Health; 2008 Jan; 81(3):285-93. PubMed ID: 17579883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a closed system device to reduce occupational contamination and exposure to antineoplastic drugs in the hospital work environment.
    Yoshida J; Tei G; Mochizuki C; Masu Y; Koda S; Kumagai S
    Ann Occup Hyg; 2009 Mar; 53(2):153-60. PubMed ID: 19261696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of cyclophosphamide in the urine of antineoplastic drugs handlers].
    Favier B; Gilles L; Desage M; Latour JF
    Bull Cancer; 2003 Oct; 90(10):905-9. PubMed ID: 14706919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid-liquid extraction procedure for trace determination of cyclophosphamide in human urine by high-performance liquid chromatography tandem mass spectrometry.
    Sottani C; Turci R; Perbellini L; Minoia C
    Rapid Commun Mass Spectrom; 1998; 12(16):1063-8. PubMed ID: 9737012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineoplastic drug residues inside homes of chemotherapy patients.
    Böhlandt A; Sverdel Y; Schierl R
    Int J Hyg Environ Health; 2017 Jun; 220(4):757-765. PubMed ID: 28372941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics of cyclophosphamide in patients with hematological malignancies.
    Xie H; Griskevicius L; Ståhle L; Hassan Z; Yasar U; Rane A; Broberg U; Kimby E; Hassan M
    Eur J Pharm Sci; 2006 Jan; 27(1):54-61. PubMed ID: 16183265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pooled analysis to study trends in exposure to antineoplastic drugs among nurses.
    Fransman W; Peelen S; Hilhorst S; Roeleveld N; Heederik D; Kromhout H
    Ann Occup Hyg; 2007 Apr; 51(3):231-9. PubMed ID: 17337460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to "Secondary Exposure of Family Members to Cyclophosphamide After Chemotherapy of Outpatients With Cancer: A Pilot Study".
    Oncol Nurs Forum; 2016 May; 43(3):268-9. PubMed ID: 27105187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occupational exposure to cyclophosphamide in nurses at a single center.
    Ramphal R; Bains T; Vaillancourt R; Osmond MH; Barrowman N
    J Occup Environ Med; 2014 Mar; 56(3):304-12. PubMed ID: 24481248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclophosphamide exposure factors in family caregivers for pediatric cancer patients.
    Noda Y; Koga Y; Yamamura K; Miyata J; Hamada Y; Ohga S
    Int J Hyg Environ Health; 2024 Jul; 260():114402. PubMed ID: 38870739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary excretion of cyclophosphamide in humans, determined by phosphorus-31 nuclear magnetic resonance spectroscopy.
    Joqueviel C; Martino R; Gilard V; Malet-Martino M; Canal P; Niemeyer U
    Drug Metab Dispos; 1998 May; 26(5):418-28. PubMed ID: 9571223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of occupational exposure to cyclophosphamide in nine hospitals of Peru].
    Rosales-Rimache JA
    Rev Peru Med Exp Salud Publica; 2013; 30(4):590-4. PubMed ID: 24448934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary elimination of cyclophosphamide alkylating metabolites and free thiols following two administration schedules of high-dose cyclophosphamide and mesna.
    Fleming RA; Cruz JM; Webb CD; Kucera GL; Perry JJ; Hurd DD
    Bone Marrow Transplant; 1996 Apr; 17(4):497-501. PubMed ID: 8722345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of sweat cyclophosphamide excretion in patients undergoing a conditioning regimen of high-dose cyclophosphamide for hematopoietic stem-cell transplantation.
    Tanigawa H; Hirohara M; Marutani Y; Suzuki Y; Onizuka M; Oda S; Orita M; Sato M; Kushida K
    J Oncol Pharm Pract; 2023 Apr; 29(3):619-625. PubMed ID: 35089101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of long-term oral chemotherapy with 5'-deoxy-5-fluorouridine and cyclophosphamide for recurrent breast cancer.
    Iba T; Kidokoro A; Fukunaga M; Sugiyama K; Aihara N; Suda M
    Int J Clin Oncol; 2004 Oct; 9(5):383-7. PubMed ID: 15549589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The determination of urinary cyclophosphamide at low concentration levels by liquid-liquid extraction and HPLC/MS/MS analysis].
    Sottani C; Turci R; Perbellini L; Minoia C
    G Ital Med Lav Ergon; 1998; 20(4):239-42. PubMed ID: 9987616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter study for environmental and biological monitoring of occupational exposure to cyclophosphamide in Japan.
    Sugiura S; Nakanishi H; Asano M; Hashida T; Tanimura M; Hama T; Nabeshima T
    J Oncol Pharm Pract; 2011 Mar; 17(1):20-8. PubMed ID: 20472603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.